{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Mirena%C2%AE", "query": { "intervention": "Mirena®" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 8, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-09T10:04:43.787Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01299116", "title": "Long-Acting Reversible Contraception", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "DMPA", "type": "DRUG" }, { "name": "oral contraceptives", "type": "DRUG" }, { "name": "Implanon®", "type": "DRUG" }, { "name": "ParaGard®", "type": "DRUG" }, { "name": "Mirena®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FHI 360", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "FEMALE", "summary": "18 Years to 29 Years · Female only" }, "enrollment_count": 916, "start_date": "2011-12", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-02-28", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01299116" }, { "nct_id": "NCT02391714", "title": "Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "IUD insertion", "type": "PROCEDURE" }, { "name": "Povidone-Iodine", "type": "DRUG" }, { "name": "Chlorhexidine", "type": "DRUG" }, { "name": "Oxygen", "type": "OTHER" }, { "name": "Nitrous oxide", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "FEMALE", "summary": "12 Years and older · Female only" }, "enrollment_count": 80, "start_date": "2013-10", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2016-02-03", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02391714" }, { "nct_id": "NCT00777556", "title": "Emergency Contraception Actual Use Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Emergency Contraception" ], "interventions": [ { "name": "DR-104", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duramed Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "16 Years", "sex": "FEMALE", "summary": "11 Years to 16 Years · Female only" }, "enrollment_count": 343, "start_date": "2008-10", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2012-10-18", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 5, "location_summary": "San Francisco, California • Atlanta, Georgia • Minneapolis, Minnesota + 2 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00777556" }, { "nct_id": "NCT02357368", "title": "Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV", "Contraception" ], "interventions": [ { "name": "Depot medroxyprogesterone acetate (DMPA)", "type": "DRUG" }, { "name": "Etonogestrel implant (Eng-Implant)", "type": "DEVICE" }, { "name": "Levonorgestrel intrauterine device (Lng-IUD)", "type": "DEVICE" }, { "name": "ParaGard® T 380A Intrauterine Copper Contraceptive", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Lisa Haddad", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 59, "start_date": "2015-02", "completion_date": "2019-10-23", "has_results": true, "last_update_posted_date": "2020-11-18", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02357368" }, { "nct_id": "NCT00584610", "title": "The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Blood Coagulation Disorders" ], "interventions": [ { "name": "Levonorgestrel-containing IUD (Mirena®)", "type": "DEVICE" }, { "name": "Copper-containing IUD (Paraguard®)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "52 Years", "sex": "FEMALE", "summary": "18 Years to 52 Years · Female only" }, "enrollment_count": 50, "start_date": "2007-12", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2010-01-18", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 1, "location_summary": "Burlington, Vermont", "locations": [ { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT00584610" }, { "nct_id": "NCT01254292", "title": "LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "Levonorgestrel IUD (LCS, BAY86-5028)", "type": "DRUG" }, { "name": "Yasmin (EE30/DRSP, BAY86-5131)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "FEMALE", "summary": "18 Years to 29 Years · Female only" }, "enrollment_count": 567, "start_date": "2011-01-06", "completion_date": "2014-05-28", "has_results": true, "last_update_posted_date": "2017-09-25", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 24, "location_summary": "Tucson, Arizona • La Mesa, California • San Diego, California + 8 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "La Mesa", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01254292" }, { "nct_id": "NCT02477202", "title": "Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Epithelial Ovarian Cancer" ], "interventions": [ { "name": "Mirena® intra-uterine device (IUD)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "35 Years to 50 Years · Female only" }, "enrollment_count": 7, "start_date": "2015-06", "completion_date": "2022-12-29", "has_results": true, "last_update_posted_date": "2023-10-16", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 6, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 3 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02477202" }, { "nct_id": "NCT00360490", "title": "Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Menorrhagia" ], "interventions": [ { "name": "Levonorgestrel IUS (Mirena, BAY86-5028)", "type": "DRUG" }, { "name": "Medroxyprogesterone acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 165, "start_date": "2006-07", "completion_date": "2008-06", "has_results": true, "last_update_posted_date": "2013-12-09", "last_synced_at": "2026-09-09T10:04:43.787Z", "location_count": 37, "location_summary": "Tucson, Arizona • Beverly Hills, California • Carmichael, California + 32 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Carmichael", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00360490" } ] }